Search results - 4 results
Variation in smoking attributable all-cause mortality across municipalities in Belgium, 2018: application of a Bayesian approach for small area estimations
national and regional estimates of smoking prevalence; however, currently there are no estimates at a smaller geographical resolution such as the municipality scale in Belgium. This hinders the estimation of ...
Reitox national reporting to EMCDDA on drugs and drug addiction, 2019
disseminate information on drugs and drug addiction in Europe. In order to fulfil the above, the EMCDDA relies on the collaboration with the European information network (Reitox), consisting of all national ...
Understanding New Psychoactive Substance (NPS) use in Belgium from a health perspective (NPS-Care)
Besides the issuing of alerts that involve the use of NPS in the context of European and national Early Warning Systems (EWS), many questions remain. Who uses NPS? How and to which degree? Why? Which ...
The European Web Survey on Drugs: patterns of use of new psychoactive substances in Belgium
cannot be easily monitored by means of the national Health Interview Survey in the general population because it is only held every five years. In addition, the questionnaire on substance use is limited ...